rivastigmine

Generic: rivastigmine

Labeler: mylan pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rivastigmine
Generic Name rivastigmine
Labeler mylan pharmaceuticals inc.
Dosage Form PATCH
Routes
TRANSDERMAL
Active Ingredients

rivastigmine 13.3 mg/24h

Manufacturer
Mylan Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 0378-9072
Product ID 0378-9072_c1d8c8a9-87e9-4ca1-ba70-4a7467205fd4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA205622
Listing Expiration 2026-12-31
Marketing Start 2018-06-20

Pharmacologic Class

Established (EPC)
cholinesterase inhibitor [epc]
Mechanism of Action
cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 03789072
Hyphenated Format 0378-9072

Supplemental Identifiers

RxCUI
725021 725023 1308569
UNII
PKI06M3IW0
NUI
N0000175723 N0000000177

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rivastigmine (source: ndc)
Generic Name rivastigmine (source: ndc)
Application Number ANDA205622 (source: ndc)
Routes
TRANSDERMAL
source: ndc

Resolved Composition

Strengths
  • 13.3 mg/24h
source: ndc
Packaging
  • 30 POUCH in 1 CARTON (0378-9072-93) / 1 PATCH in 1 POUCH (0378-9072-16) / 24 h in 1 PATCH
source: ndc

Packages (1)

0378-9072-93 30 POUCH in 1 CARTON (0378-9072-93) / 1 PATCH in 1 POUCH (0378-9072-16) / 24 h in 1 PATCH

Ingredients (1)

rivastigmine (13.3 mg/24h)

Linked Drug Pages (1)

Rivastigmine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TRANSDERMAL"], "spl_id": "c1d8c8a9-87e9-4ca1-ba70-4a7467205fd4", "openfda": {"nui": ["N0000175723", "N0000000177"], "unii": ["PKI06M3IW0"], "rxcui": ["725021", "725023", "1308569"], "spl_set_id": ["4ab335d1-19ee-4cd9-9776-8086645d19e4"], "pharm_class_epc": ["Cholinesterase Inhibitor [EPC]"], "pharm_class_moa": ["Cholinesterase Inhibitors [MoA]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 POUCH in 1 CARTON (0378-9072-93)  / 1 PATCH in 1 POUCH (0378-9072-16)  / 24 h in 1 PATCH", "package_ndc": "0378-9072-93", "marketing_start_date": "20180620"}], "brand_name": "Rivastigmine", "product_id": "0378-9072_c1d8c8a9-87e9-4ca1-ba70-4a7467205fd4", "dosage_form": "PATCH", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "0378-9072", "generic_name": "rivastigmine", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivastigmine", "active_ingredients": [{"name": "RIVASTIGMINE", "strength": "13.3 mg/24h"}], "application_number": "ANDA205622", "marketing_category": "ANDA", "marketing_start_date": "20180620", "listing_expiration_date": "20261231"}